GR 47701; (June, 1941) (CRITIQUE)
__________________________________________________________________
THE AI-ASSISTED CRITIQUE
The Court of Appeals’ application of section 69 of the Corporation Law to bar the foreign corporation’s suit was a rigid and formalistic interpretation that prioritized corporate licensing formalities over substantive intellectual property rights. By concluding that the exclusive distributor arrangement constituted “transacting business,” the court effectively allowed a technical procedural defense to defeat a claim of clear trademark infringement and unfair competition, as evidenced by the defendants’ use of Mentholiman in packaging nearly identical to Mentholatum. This elevates a licensing requirement meant to regulate ongoing commercial presence into an absolute barrier to judicial recourse, potentially shielding local infringers whenever a foreign rights-holder utilizes a local agent—a result contrary to the protective purpose of trademark law and the principle of dammum absque injuria, as it permits a clear legal injury to go unremedied.

The decision’s reasoning is further flawed in its failure to properly distinguish between “doing business” for licensing purposes and maintaining a suit to protect a specific, registered intellectual property right. The true test cited from foreign jurisprudence—whether the corporation is continuing the substance of its business—was misapplied to a scenario involving isolated acts of importation and distribution through an independent local entity. The court’s reliance on the complaint’s description of an “exclusive distributing agent” as a conclusive admission ignored the practical reality of arm’s-length transactions and transformed a distribution agreement into a legal alter ego, a conclusion not necessarily compelled by the facts. This conflation creates legal uncertainty for foreign entities seeking to protect trademarks without establishing a full commercial presence, undermining the stability of intellectual property rights in international commerce.

Finally, the appellate court committed a significant error by dismissing the entire complaint without separately considering the standing and rights of the co-petitioner, the Philippine-American Drug Co., Inc., a domestic corporation. Even assuming the foreign parent was barred, the local exclusive distributor had a direct and substantial interest in preventing consumer confusion and loss of sales from the infringing product. The court’s blanket dismissal, based solely on the foreign corporation’s disability, constitutes a failure to adjudicate the merits of the domestic party’s independent claim, violating the principle that justice requires deciding cases on their substantive merits rather than procedural technicalities. This oversight allowed a potentially meritorious claim for unfair competition to be extinguished without a hearing, setting a problematic precedent that could frustrate enforcement of intellectual property rights through legitimate local partners.